Telomerase
US6921664B2 · kind B2 · utility
12Cited by
33References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 18, 2002 |
| Grant date | Jul 26, 2005 |
| Priority date | — |
| Expiry date | Oct 16, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/315
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to expression vectors comprising a polynucleotide that encodes a human telomerase reverse transcriptase (hTRT) protein, variant, or fragment. The present invention is also directed to host cells that comprise expression vectors comprising a polynucleotide that encodes a hTRT protein variant, or fragment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.